| William Andrew Zeitler, MD | |
|
200 Hawkins Dr, Iowa City, IA 52242-1009 | |
| (319) 356-2148 | |
| (319) 353-8383 |
| Full Name | William Andrew Zeitler |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 11 Years |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013356096 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD-43606 (Iowa) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD-43606 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Iowa Hospital & Clinics | Iowa city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| State University Of Iowa | 7618884230 | 1476 |
News Archive
Reuters/ABC News reports on research published in the Journal of the American Medical Association that examined the misuse of two blood thinners - Lovenox and Integrilin - in "about 20 percent of kidney dialysis patients who undergo a procedure to open a blocked artery [who] are given the wrong blood clot medicine, increasing the chances of significant bleeding, researchers said Tuesday.
Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Granisetron Hydrochloride Tablets USP, 1 mg (base) ("granisetron tablets").
The Providence Service Corporation today announced that it has completed the renewal cycle with all of its payers for its fiscal 2010-2011 contract renewal cycle and expects an overall net gain in contract value primarily as a result of increased volume.
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today on the occasion of the 29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), the recipients of the company's inaugural Grant for Multiple Sclerosis Innovation (GMSI).
› Verified 1 days ago
| Entity Name | State University Of Iowa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477554814 PECOS PAC ID: 7618884230 Enrollment ID: O20031107000060 |
News Archive
Reuters/ABC News reports on research published in the Journal of the American Medical Association that examined the misuse of two blood thinners - Lovenox and Integrilin - in "about 20 percent of kidney dialysis patients who undergo a procedure to open a blocked artery [who] are given the wrong blood clot medicine, increasing the chances of significant bleeding, researchers said Tuesday.
Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Granisetron Hydrochloride Tablets USP, 1 mg (base) ("granisetron tablets").
The Providence Service Corporation today announced that it has completed the renewal cycle with all of its payers for its fiscal 2010-2011 contract renewal cycle and expects an overall net gain in contract value primarily as a result of increased volume.
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today on the occasion of the 29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), the recipients of the company's inaugural Grant for Multiple Sclerosis Innovation (GMSI).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Andrew Zeitler, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-2148 | William Andrew Zeitler, MD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-2148 |
News Archive
Reuters/ABC News reports on research published in the Journal of the American Medical Association that examined the misuse of two blood thinners - Lovenox and Integrilin - in "about 20 percent of kidney dialysis patients who undergo a procedure to open a blocked artery [who] are given the wrong blood clot medicine, increasing the chances of significant bleeding, researchers said Tuesday.
Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.
Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Granisetron Hydrochloride Tablets USP, 1 mg (base) ("granisetron tablets").
The Providence Service Corporation today announced that it has completed the renewal cycle with all of its payers for its fiscal 2010-2011 contract renewal cycle and expects an overall net gain in contract value primarily as a result of increased volume.
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today on the occasion of the 29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), the recipients of the company's inaugural Grant for Multiple Sclerosis Innovation (GMSI).
› Verified 1 days ago
Rami G. El Abiad, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4901 Fax: 319-384-8559 | |
Grerk Sutamtewagul, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Dept Of Internal Medicine, Iowa City, IA 52242 Phone: 319-356-1616 Fax: 319-353-8383 | |
Dr. Kaleb Tanner Veit, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Drive, Iowa City, IA 52242 Phone: 319-353-6239 Fax: 319-353-6406 | |
Dr. Elizabeth R Bowen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Department Of Internal Medicine, Iowa City, IA 52242 Phone: 319-353-7842 Fax: 319-353-7850 | |
Balarama Krishna Surapaneni, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-4019 Fax: 319-353-8073 | |
Soorih Shaikh, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2148 Fax: 319-353-8383 | |
Dr. Richard Ellis Larew, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2460 Towncrest Dr, Iowa City, IA 52240 Phone: 319-338-7862 |